Dr. Sheena M Ogando is a San Diego, California based female rheumatologist who is specialized in Rheumatology. Active license number of Dr. Sheena M Ogando for Rheumatology is A142743 in California. Dr. Sheena M Ogando treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Sheena M Ogando speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
M.D.
Gender:
Female
Practice Address:
4725 Market St, San Diego, California, 92102-4715
Phone:
619-515-2560
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1649564295
NPI Enumeration Date:
31 May, 2011
NPI Last Update On:
25 Aug, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Sheena M Ogando are as mentioned below.
License Number
Specialization
State
Status
A142743
Rheumatologist
California
Primary
Student in an Organized Health Care Education/Training Program
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
823 Gateway Center Way, San Diego, California
Zip:
92102-4541
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Sheena M Ogando at 4725 Market St, San Diego, California or can call to book an appointment on 619-515-2560. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.